Skip to main content

Home/ Cancer/ Group items matching "Merajver" in title, tags, annotations or url

Group items matching
in title, tags, annotations or url

Sort By: Relevance | Date Filter: All | Bookmarks | Topics Simple Middle
Matti Narkia

Cancer Therapy With Tetrathiomolybdate: Antiangiogenesis by Lowering Body Copper-A Review -- Brewer and Merajver 1 (4): 327 -- Integrative Cancer Therapies - 0 views

ict.sagepub.com/...327

Cancer Therapy Tetrathiomolybdate anti-angiogenesis anti-angiogenic anti-copper agent angiogenesis Copper Review reduction inhibition inhibitor inhibitors treatment science study medicine medline peer-reviewed oncology imported delicious

shared by Matti Narkia on 24 Feb 09 - Cached
  • Matti Narkia on 24 Feb 09
     
    Brewer GJ, Merajver SD. Cancer therapy with tetrathiomolybdate: antiangiogenesis by lowering body copper--a review. Integr Cancer Ther. 2002 Dec;1(4):327-37. Review. PMID: 14664727 [PubMed - indexed for MEDLINE]
Matti Narkia

Copper Deficiency Induced by Tetrathiomolybdate Suppresses Tumor Growth and Angiogenesis -- Pan et al. 62 (17): 4854 -- Cancer Research - 0 views

cancerres.aacrjournals.org/...4854

Copper Deficiency Tetrathiomolybdate Suppresses Tumor cancer Growth Angiogenesis anti-copper anti-angiogenesis anti-angiogenic agent inhibition inhibitor inhibitors medicine medline oncology science study research peer-reviewed treatment therapy imported

shared by Matti Narkia on 24 Feb 09 - Cached
  • Matti Narkia on 24 Feb 09
     
    Q. Pan, C. G. Kleer, K. L. van Golen, J. Irani, K. M. Bottema, C. Bias, M. De Carvalho, E. A. Mesri, D. M. Robins, R. D. Dick, G. J. Brewer, and S. D. Merajver Copper Deficiency Induced by Tetrathiomolybdate Suppresses Tumor Growth and Angiogenesis Canc
Matti Narkia

Phase II Trial of Tetrathiomolybdate in Patients with Advanced Kidney Cancer -- Redman et al. 9 (5): 1666 -- Clinical Cancer Research - 0 views

clincancerres.aacrjournals.org/...1666

Phase-II phaseII Trial Tetrathiomolybdate Advanced Kidney Cancer renal kidneycancer clinicaltrial anti-angiogenesis anti-angiogenic anti-copper agent angiogenesis copper inhibition inhibitor inhibitors reduction medicine medline oncology science study res

shared by Matti Narkia on 24 Feb 09 - Cached
  • Matti Narkia on 24 Feb 09
     
    B. G. Redman, P. Esper, Q. Pan, R. L. Dunn, H. K. Hussain, T. Chenevert, G. J. Brewer, and S. D. Merajver Phase II Trial of Tetrathiomolybdate in Patients with Advanced Kidney Cancer Clin. Cancer Res., May 1, 2003; 9(5): 1666 - 1672.
Matti Narkia

Inhibition of the Growth of Squamous Cell Carcinoma by Tetrathiomolybdate-Induced Copper Suppression in a Murine Model, July 2003, Cox et al. 129 (7): 781 -- Arch Otolaryngol Head Neck Surg - 0 views

archotol.ama-assn.org/...781

Inhibition Growth Squamous Cell Carcinoma Tetrathiomolybdate Copper Suppression cancer anti-angiogenesis anti-angiogenic anti-copper agent angiogenesis inhibitor inhibitors reduction head neck scc medicine medline science study research head_and_nec SCCHN

shared by Matti Narkia on 24 Feb 09 - Cached
  • Matti Narkia on 24 Feb 09
     
    C. Cox, S. D. Merajver, S. Yoo, R. D. Dick, G. J. Brewer, J. S.-J. Lee, and T. N. Teknos Inhibition of the Growth of Squamous Cell Carcinoma by Tetrathiomolybdate-Induced Copper Suppression in a Murine Model Arch Otolaryngol Head Neck Surg, July 1, 200
Matti Narkia

Antiangiogenic Tetrathiomolybdate Enhances the Efficacy of Doxorubicin against Breast Carcinoma -- Pan et al. 2 (7): 617 -- Molecular Cancer Therapeutics - 0 views

mct.aacrjournals.org/...617

anti-angiogenic anti-angiogenesis anti-copper angiogenesis Tetrathiomolybdate Doxorubicin Breast Carcinoma cancer chemotherapy agent inhibition inhibitor inhibitors copper reduction science study research medicine medline peer-reviewed impor breast_cancer

shared by Matti Narkia on 24 Feb 09 - Cached
  • Matti Narkia on 24 Feb 09
     
    Pan Q, Bao LW, Kleer CG, Brewer GJ, Merajver SD. Antiangiogenic tetrathiomolybdate enhances the efficacy of doxorubicin against breast carcinoma. Mol Cancer Ther. 2003 Jul;2(7):617-22. PMID: 12883034 [PubMed - indexed for MEDLINE]
Matti Narkia

Tetrathiomolybdate promotes tumor necrosis and prevents distant metastases by suppressing angiogenesis in head and neck cancer -- Hassouneh et al. 6 (3): 1039 -- Molecular Cancer Therapeutics - 0 views

mct.aacrjournals.org/...1039

Hassouneh B Islam M Nagel T Pan Q Merajver SD Teknos TN. Tetrathiomolybdate promotes tumor necrosis and prevents distant metastases by suppressing angiogenesis in head neck cancer. Mol Cancer Ther. 2007 Mar;6(3):1039-45. PMID: 17363496 [PubMed inhibi

shared by Matti Narkia on 24 Feb 09 - Cached
  • Matti Narkia on 24 Feb 09
     
    Tetrathiomolybdate promotes tumor necrosis and prevents distant metastases by suppressing angiogenesis in head and neck cancer -- Hassouneh et al. 6 (3): 1039 -- Molecular Cancer Therapeutics
Matti Narkia

Treatment of Metastatic Cancer with Tetrathiomolybdate, an Anticopper, Antiangiogenic Agent: Phase I Study -- Brewer et al. 6 (1): 1 -- Clinical Cancer Research - 0 views

clincancerres.aacrjournals.org/...1

Brewer GJ Dick RD Grover DK LeClaire V Tseng M Wicha Pienta K Redman BG Jahan T Sondak VK Strawderman LeCarpentier G Merajver SD. Treatment of metastatic cancer with tetrathiomolybdate an anticopper antiangiogenic agent: Phase I study. Tetrath

shared by Matti Narkia on 24 Feb 09 - Cached
  • Matti Narkia on 24 Feb 09
     
    Treatment of Metastatic Cancer with Tetrathiomolybdate, an Anticopper, Antiangiogenic Agent: Phase I Study -- Brewer et al. 6 (1): 1 -- Clinical Cancer Research
1 - 7 of 7
Showing 20▼ items per page